| Patient | Martin Luther King |
|---|---|
| Date of birth | 1990-01-15 |
| Identifiers | MRN HR-ML001-SYN; SSN (made up) 000-01-4058 |
| Document date | 2026-07-14 |
| Author | Cornelius Ashby-Nwankwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Fourteen-week review: mood, sleep, varenicline, blood pressure and the work plan. [S]
Dr. King returns six weeks after his eight-week review, just back from a two-week break with his family, the first he has taken in years. He had a video review with Dr. Lindqvist-Bankole last month, who agreed with the plan. His mood is clearly better; he enjoys reading and preaching again and sleeps about six and a half hours. He had one lapse in June, smoking three cigarettes late one night after a threatening call, and has not smoked since. He finishes twelve weeks of varenicline in about four weeks. Home readings over the past week averaged 132/84. He walks most mornings when he is at home and has cut back on fried food. He has no thoughts of harming himself. [S]
| Element | Detail |
|---|---|
| Break | Two weeks away; first in years |
| Mood | Better; PHQ-9 8 |
| Smoking | One lapse of three cigarettes in June; smoke-free since |
| Home blood pressure | Average 132/84 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Rested; more energy |
| Respiratory | Negative | No cough |
| Cardiovascular | Negative | No chest pain or palpitations |
| Psychiatric | Positive | Mood mostly good; still watchful in crowds; no suicidal ideation |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg tablet, one by mouth once daily for 3 days, then twice daily for 4 days | once daily for 3 days, then twice daily for 4 days, after food | Oral route | 2026-05-12 to 2026-05-19 | completed | S |
| Varenicline 1 mg tablet, one by mouth twice daily after food | twice daily after food | Oral route | 2026-05-19 | active | S |
| Sertraline 25 mg tablet, one by mouth each morning for one week | once daily in the morning | Oral route | 2026-04-20 to 2026-04-27 | completed | S |
| Sertraline 50 mg tablet, one by mouth each morning | once daily in the morning | Oral route | 2026-04-27 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-14 | Body height | 170 | cm | S |
| 2026-07-14 | Body weight | 84 | kg | S |
| 2026-07-14 | Body mass index (BMI) [Ratio] | 29.1 | kg/m2 | S |
| 2026-07-14 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-07-14 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 2026-07-14 | Heart rate | 72 | /min | S |
| 2026-07-14 | Respiratory rate | 14 | /min | S |
| 2026-07-14 | Body temperature | 36.6 | Cel | S |
| 2026-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-14 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 8 | {score} | S | ||
| 2026-07-14 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 5 | {score} | S | ||
| 2026-07-14 | PC-PTSD-5 score [PC-PTSD-5] | 1 | {score} | S |
Vital signs recorded on 2026-07-14; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Rested; blood pressure 130/84, pulse 72; weight 84.0 kg, BMI 29.1 |
| Cardiovascular | Regular rhythm; no murmur |
| Psychiatric | Euthymic, warm, reactive affect; no suicidal ideation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Exhaustion, broken sleep and low mood for about two months, under sustained threats and a punishing schedule, after an admission for exhaustion and a respiratory infection six months ago; cause not established at intake: a depressive disorder, an adjustment disorder, PTSD, an insomnia disorder, thyroid disease and anemia to be assessed; psychiatry consultation requested | resolved | confirmed | R53.83 | S — Synthetic presenting problem anchored to his documented admission for exhaustion and the threats against him; superseded by the diagnoses at the second visit. |
| Major depressive disorder, single episode, moderate (DSM-5-TR), arising under chronic threat, surveillance and overwork; no suicidal ideation; PTSD not present on screening and interview | active | confirmed | F32.1 | S — Synthetic modern diagnosis made at the psychiatry consultation, linked to his documented exhaustion and threats and to biographers' accounts of depression (R); not a claim that he was so diagnosed. |
| Insomnia disorder (DSM-5-TR), comorbid with depression: trouble falling and staying asleep at least four nights a week for over three months, with short sleep from late-night work and travel | active | confirmed | G47.00 | S — Synthetic modern diagnosis made at the psychiatry consultation. |
| Nicotine dependence, cigarettes: about a pack a day since his twenties, smoked out of public view | active | confirmed | F17.210 | S — Synthetic modern problem anchored to the documented account of his heavy, hidden smoking. |
| Elevated blood pressure readings in the clinic (138/88 mmHg) without a diagnosis of hypertension; home monitoring to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding; superseded by the diagnosis at the six-week visit. |
| Healed stab wound of the left chest, repaired by thoracotomy seven years ago; occasional aching along the scar with coughing and in cold weather, without exertional or ischemic features | active | confirmed | Z87.828 | S — Synthetic modern problem anchored to his documented stabbing and chest surgery in 1958. |
| Stage 1 hypertension (2017 ACC/AHA), confirmed by home readings averaging 136/86 mmHg; no end-organ damage (normal ECG, urine albumin, kidney function and fundi); low estimated 10-year risk; lifestyle treatment | active | confirmed | I10 | S — Synthetic modern diagnosis made at the eight-week visit; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | At least monthly during acute treatment; every 2 to 4 weeks in continuation | Completed today | 8, a 53 percent fall from 17 |
| Survey | GAD-7 | Every 4 to 8 weeks during treatment | Completed today | 5 |
| Survey | PTSD screen (PC-PTSD-5) | Repeat at about three months and if trauma symptoms emerge | Completed today | 1: on guard only; no PTSD |
| Survey | Suicide risk reassessment (C-SSRS Since Last Visit and PHQ-9 item 9) | Every visit | Completed today | No suicidal ideation; PHQ-9 item 9 scored 0. Safety plan reviewed |
| Referral | Psychiatry follow-up | At about eight to twelve weeks | Completed today | Video review with Dr. Lindqvist-Bankole last month; plan unchanged |
| Medication safety | Adherence and adverse-effect review | Every visit | Completed today | No missed sertraline doses; nausea on varenicline has settled |
| Self-management | Smoking status after the quit date | Every visit | Completed today | One lapse in June; smoke-free since |
| Survey | Insomnia Severity Index and sleep diary | Every visit during CBT for insomnia | Completed today | Insomnia Severity Index 10; about six and a half hours a night (score in the notes; no LOINC code used) |
| Examination | Home blood pressure readings | A week before each visit while treatment is adjusted | Completed today | Seven-day average 132/84 |
| Examination | Office blood pressure, weight and BMI | Every visit | Completed today | 130/84 mmHg; weight 84.0 kg |
| Self-management | Sustainable work plan: a day off each week, two speeches a day at most, sleep window kept | Every visit | Completed today | Day off kept most weeks; two-week break taken |
Goal progress:
Guideline basis: Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders, hypertension and hyperlipidemia monographs (2026); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES) (2016); 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2017)
Follow-up: Review in nine weeks with repeat lipids. Next scheduled visit 2026-09-15: twenty-three-week review: remission, smoking, blood pressure and lipids. [S]